StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp (EW) stock

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$105.43−1.68 (-1.57%)

Close on Nov 17, 2026Market cap $60.77BP/E 60.6Yield –

Edwards Lifesciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Edwards Lifesciences's market cap was $61.01B on Nov 11, 2026, against $50.33B a year earlier. Over the last 5 years it ranged from $37.98B to $80.87B, with a median of $49.50B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$61.01B+23.2%
2025Dec 31, 2025$49.50B+13.4%
2024Dec 31, 2024$43.66B-5.6%
2023Dec 29, 2023$46.25B+0.1%
2022Dec 30, 2022$46.21B-42.9%
2021Dec 31, 2021$80.87B+42.3%
2020Dec 31, 2020$56.83B+16.8%
2019Dec 31, 2019$48.64B+51.9%
2018Dec 31, 2018$32.03B+34.3%
2017Dec 29, 2017$23.85B+19.1%
2016Dec 30, 2016$20.02B+17.7%
2015Dec 31, 2015$17.01B+24.9%
2014Dec 31, 2014$13.62B+89.3%
2013Dec 31, 2013$7.19B-31.2%
2012Dec 31, 2012$10.46B+29.5%
2011Dec 30, 2011$8.07B-12.5%
2010Dec 31, 2010$9.22B+78.2%
2009Dec 31, 2009$5.18B–

More Edwards Lifesciences figures

See a number that looks wrong?